Product Information

IMIPRAMINE HCL 50 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1574 per EA under NDC 69315013510. Its NADAC has been published 550 times since May 11, 2016.

FDA first approved this application on Oct 24, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IMIPRAMINE HCL 50 MG TABLET

Imipramine Hydrochloride
$0.1574per EA

Strength

50 mg/1

NDC

69315013510

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IMIPRAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA040903

FDA Approved

10/24/2012

TE Code

AB

On Market Since

4/7/2016

Pharmacological Classes

Price Statistics

The NADAC for IMIPRAMINE HCL 50 MG TABLET has been published 550 times since May 11, 2016, and over the history we have for it it has declined 23.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1574 per EA
All-time high$0.2389 (Sep 13, 2017)
All-time low$0.0932 (Nov 20, 2024)
52-week high$0.1685
52-week low$0.1240
Median price$0.1504
Average price$0.1549
Largest weekly change-32.3% (Jul 17, 2019)
Weeks tracked550
Tracking sinceMay 11, 2016

Price History

1W

+3.0%

1M

+1.1%

3M

+2.4%

6M

+26.5%

1Y

+11.9%

3Y

+57.7%

5Y

-1.8%

All

-23.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMIPRAMINE HCL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 50 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1574 per EA (NDC 69315013510), effective Nov 18, 2026.

How has the price of IMIPRAMINE HCL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for IMIPRAMINE HCL 50 MG TABLET has declined 23.3%. It has been tracked across 550 weekly CMS publications since May 11, 2016.

What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 50 MG TABLET?

Since May 11, 2016, the NADAC for IMIPRAMINE HCL 50 MG TABLET has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.2389 (Sep 13, 2017), with a median of $0.1504 per EA.

Are there cheaper alternatives to IMIPRAMINE HCL 50 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMIPRAMINE HCL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IMIPRAMINE HCL 50 MG TABLET?

IMIPRAMINE HCL 50 MG TABLET (NDC 69315013510) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.